Publications by authors named "N Slater"

Background: Normal cognitive function is supported by the neuromodulatory mechanisms of the cholinergic system. In Parkinson's disease (PD), histological and molecular imaging evidence suggests disruption to cholinergic circuitry is associated with progression to Parkinson's disease dementia (PDD). The primary source of cortical cholinergic input is the Ch4 region of the basal forebrain.

View Article and Find Full Text PDF
Article Synopsis
  • Cognitive impairment is a significant symptom of Parkinson's disease, primarily linked to the deterioration of the cholinergic system in the brain.
  • Studies utilizing postmortem data and PET scans indicate notable changes in the cholinergic system in patients, particularly those with Parkinson's dementia.
  • This review highlights MRI as a cost-effective method to investigate structural changes in parts of the brain related to cognition, noting that reductions in a specific area (Ch4) could help predict cognitive decline in these patients, although more research is needed to fully understand these changes, especially in early cognitive decline stages.
View Article and Find Full Text PDF

In the realm of combined cancer immunotherapy, the strategic combination of therapeutics targeting both cancer cells and macrophages holds immense potential. However, the major challenges remain on how to achieve facile spatiotemporal delivery of these therapies, allowing ease of manipulation and ensuring differential drug release for enhanced synergistic therapeutic effects. In the present study, we introduced a tumor microenvironment (TME)-adapted hydrogel with the phenylboronic acid-modified dipyridamole prodrug (DIPP) as a crosslinker.

View Article and Find Full Text PDF

Objectives: Patients with recurrent squamous cell carcinoma of the head and neck (HNSCC) have a poor prognosis and limited therapeutic alternatives. While reirradiation is feasible, it is usually associated with high treatment toxicity and is not yet considered the standard of care. Based on current NCCN guidelines, in the context of very advanced head and neck cancer (recurrent and/or persistent disease), surgical intervention is explored initially with/without adjuvants while unresectable disease is approached with radiation and/or systemic therapies.

View Article and Find Full Text PDF